In the muscle biopsy cohort, the risk for higher mortality in an ALS patient showing high Collagen type XIX, alpha 1 (COL19A1) protein levels and a fast progression of the disease was ~71%, while in the blood cohort, this risk was 20%. Here, COL19A1 is linked to amyotrophic lateral sclerosis.